) Director & Senior Vice President Nawarat Patanakarn Public Company Limited NAWARAT PATANAKARN PUBLIC COMPANY LIMITED SUMMARY OF FINANCIAL POSITION AND PERFORMANCE FOR THE PERIOD OF ONE YEAR ENDED DECEMBER 31
& Senior Vice President Nawarat Patanakarn Public Company Limited (Translation) NAWARAT PATANAKARN PUBLIC COMPANY LIMITED SUMMARY OF FINANCIAL POSITION AND PERFORMANCE FOR THE PERIOD OF ONE THREE MONTHS
Microsoft Word - Performance Q3_2561_English_ (Translation) NAWARAT PATANAKARN PUBLIC COMPANY LIMITED SUMMARY OF FINANCIAL POSITION AND PERFORMANCE FOR THE PERIOD OF THREE MONTHS ENDED SEPTEMBER 30
transaction tendency, and preventive approaches against conflicts of interest. 12 Part 4 Financial Position and Operating Results 13. Significant financial information Demonstrate information from the financial
Directot After entering into the transaction, the Company shall appoint 2 persons as the Company’s representatives holding a position of NEXT’s director who are authorized, altogether with the existing
the transaction, the Company shall appoint 2 persons as the Company’s representatives holding a position of NEXT’s director who are authorized, altogether with the existing directors of NEXT to sign on
Bulsuk (3) Dr. Sucharit Koontanakulvong 2. Approved the connected transaction with the related companies. (Details as attachment) Please be informed accordingly Yours sincerely, Kiyoyasu Asanuma Managing
), with the Bank’s capital position expected to remain robust post acquisition 8. Sources of Funds to Finance the Purchase The Bank expects the Transaction to be financed via combination of internal
Type 2 Transaction (List 1). DOD Biotech Public Company Limited (the “Company”) hereby notifies the significant resolutions passed by the Board of Directors’ Meeting No. 8/2018, held on December 19, 2018
financial statement as of 30 September 2017, the transaction size is of the highest value when calculated from net tangible asset test, which is equivalent to 14.48 per cent. According to the Notifications of